CannTrust's Fourth Quarter Financial Results Show Strong Sales But Declining Profits

Sales are up, but profits are on the decline for CannTrust Holdings Inc. (NYSE: CTST) as the company releases their financial results for the fourth quarter and year ending on December 31, 2018.

Revenue for the company increased to $16.2 million, representing an increase of 132% over the same quarter in the previous year. This rise in revenue was attributed to the start of recreational cannabis sales in Canada. However, some of those increased sales were offset by excise taxes on medical cannabis products; approximately $0.9 million.

“The CannTrust team has delivered remarkable growth in the fourth quarter of 2018. We achieved record sales volume, record revenue and our medical patient count continues to increase, reflecting the quality of our products and customer service,” said CannTrust CEO Peter Aceto.

In the fourth quarter, CannTrust sold 3,407 kilograms of cannabis, which is up from the 758 kilograms that the company sold in the same period in 2017. Over the last year, the company increased its active cannabis patient count from 37,000 to 58,000.

The company’s cash cost per gram declined by 42%, falling from $5.16 to $2.94. However, gross margins before fair value changes to biological assets also declined, falling from 69% in the third quarter to just 35%.  Management has attributed the steep drop off to lower pricing on wholesale sales, excise taxes on medical cannabis sales, and the fact that the company is not yet operating at full production capacity.

Similarly, adjusted EBITDA declined as well; dropping from a loss of $0.9 million to a loss of $8.5 million. The company claims that the increased losses were a result of deliberate investments in support of growth efforts; such as marketing costs to launch four recreational cannabis brands, international strategy, personnel, and the costs associated with preparing the company to list its stock on the New York Stock Exchange.

Despite its losses, CannTrust still has 72.0 million in cash and short-term investments, and a working capital position of $111.6 million. CannTrust’s stock is currently trading at or around $8.30 per share.

William Sumner

William Sumner

William Sumner is a freelance writer specializing in the legal cannabis industry. You can follow William on Twitter @W_Sumner or on Medium.


Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

Our biggest fans this week: BeckyViator. Thank you! via

@GreenMarketRpt – 3 days

My week on Twitter 🎉: 10 Mentions, 129K Mention Reach, 4 Likes, 2 Retweets, 32 Retweet Reach. See yours with…

@GreenMarketRpt – 3 days

RT : EXCLUSIVE: sues $DYME $DYMEF as the stock resumes trading. Gotham Green asks for its money back. Co plans layoffs,…

Back to Top

You have Successfully Subscribed!